Tracking medicines to prevent counterfeits in the US

An article in Bloombergbusinessweek (June 3,2013) describes a plan to install a digital ID on tablet bottles to track them as they move through the supply chain. Individual companies would have to be registered in the Federal licenses and subject their employees to background checks to operate. But others in Congress want tracking of bulk shipments, not individual doses. How should the level of tracking be chosen to minimize counterfeits while managing their impact on costs ? Will more control of pharmacies be necessary to prevent the deaths caused by facilities like the Boston compounding pharmacy ?

Advertisements

About aviyer2010

Professor
This entry was posted in Operations Management, Service Operations, Supply Chain Issues and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s